Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Extraordinary measures: what are the benefits to have such movies talking about Rare Diseases?

Diabetes management during Ramadan

Risk for post-operative Venous Thromboembolism in patients receiving Enoxaparin Prophylaxis

Experts Perspective

The Stigma of Rare Diseases

Prurigo Nodularis is a distinct, Chronic, Neural and Immune- Mediated skin disease characterized by intense itch and Nodular Lesions¹

The role and importance of Patients Associations and Scientific societies ; Oman Experience

Multidisciplinary approaches in Rare Disease Patient management

Type 2 Inflammation may play a role in Prurigo Nodularis Pathophysiology1

Exact pathophysiology of PN is currently not understood. Based on the evolving literature, type 2 inflammation may play a role in PN.

How is LSDs prevalence & epidemiology different in our region?

Global use of RAM and Thromboprophylaxis in hospitalized patients

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.